With the analysis among 395 patents, we discovered top 53 key players by total patent application. ChemoCentryx, Inc., Reviva Pharmaceuticals, Inc., Biopharm Ltd. are dominant in this area. They take 36.71% of the total patent filing.
California, United States
Patent: 69
California, United States
Patent: 57
Nordrhein-Westfalen, Germany
Patent: 17
Maharashtra, India
Patent: 13
Hessen, Germany
Patent: 11
No data, please try another search term
With the analysis among related 23 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Reviva Pharmaceuticals, Inc., Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 69.57% of patent filing during this period.
California, United States
Patent: 10
Shanghai Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 3
California, United States
Patent: 1
Mazowieckie, Poland
Patent: 1
With the analysis among related 23 patents in last 5 years, we discover 5 new entrants. Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Defense Research & Development Organization are the most active new entrants in this area.
Shanghai Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 3
Mazowieckie, Poland
Patent: 1
With the analysis among 58 patents, we discovered top 7 universities and scientific research institutions by total patent application. Universidad Complutense de Madrid, Shanghai Institute of Pharmaceutical Industry, Guangzhou Medical University are dominant in this area. They take 68.97% of the total patent filing.
Shanghai Shi, China
Patent: 5
Guangdong Sheng, China
Patent: 4
Henan Sheng, China
Patent: 2
Mazowieckie, Poland
Patent: 1
Tianjin Shi, China
Patent: 1